AstaReal marks anniversary of pioneering astaxanthin developments

摘要

AstaReal Group, the global leader in natural astaxanthin cultivation and clinical science, is celebrating 30 years of research and innovation. Having studied the microalga Haematococcus pluvialis since 1988, the company is at the forefront of the natural astaxanthin industry. Throughout the last three decades, AstaReal has not only dedicated itself to producing high-quality natural astaxanthin products, but also to investing in extensive clinical research. As a result, the organisation is globally recognised as an authority in natural astaxanthin science with a portfolio of nearly 60 human clinical trials - making AstaReal® the most widely researched brand of natural astaxanthin on the market. This year, the group will highlight important milestones in their journey from being a Swedish start-up to a market leading business with two state-of-the-art production facilities and offices strategically located around the world. Dr Åke Lignell, founder and now Director of R&D at AstaReal Sweden, says: "To see how our company has grown during the past three decades is truly amazing. I am proud to say that research and innovation has remained a core value at AstaReal and is present in our daily mission."